Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rauchhaus

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|May 4, 2001
Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influenceH B Schmidt, M Rauchhaus, D P Francis, et al.
European Heart Journal|December 28, 1999
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart diseaseF Leyva, M Rauchhaus, S D Anker, et al.
Journal of Critical Care|February 18, 2014
Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndromeH Schmidt, U Lotze, A Ghanem, et al.
Clinical Pharmacology and Therapeutics|September 10, 2010
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinolS von Haehling, S M Bode-Böger, J Martens-Lobenhoffer, et al.
Circulation|January 11, 2000
Plasma cytokine parameters and mortality in patients with chronic heart failureM Rauchhaus, W Doehner, D P Francis, et al.
European Heart Journal|April 20, 1999
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failureS D Anker, P P Ponikowski, A L Clark, et al.
Deutsche Medizinische Wochenschrift (1946)|November 21, 2008
[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]R Hennen, I Friedrich, D Hoyer, et al.
European Journal of Endocrinology|November 27, 2001
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexiaW Doehner, C D Pflaum, M Rauchhaus, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 6, 2011
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart FailureC Zugck, J Franke, G Gelbrich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2014
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registryW von Scheidt, C Zugck, M Pauschinger, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|May 4, 2001
Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influenceH B Schmidt, M Rauchhaus, D P Francis, et al.
European Heart Journal|December 28, 1999
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart diseaseF Leyva, M Rauchhaus, S D Anker, et al.
Journal of Critical Care|February 18, 2014
Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndromeH Schmidt, U Lotze, A Ghanem, et al.
Clinical Pharmacology and Therapeutics|September 10, 2010
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinolS von Haehling, S M Bode-Böger, J Martens-Lobenhoffer, et al.
Circulation|January 11, 2000
Plasma cytokine parameters and mortality in patients with chronic heart failureM Rauchhaus, W Doehner, D P Francis, et al.
European Heart Journal|April 20, 1999
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failureS D Anker, P P Ponikowski, A L Clark, et al.
Deutsche Medizinische Wochenschrift (1946)|November 21, 2008
[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]R Hennen, I Friedrich, D Hoyer, et al.
European Journal of Endocrinology|November 27, 2001
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexiaW Doehner, C D Pflaum, M Rauchhaus, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 6, 2011
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart FailureC Zugck, J Franke, G Gelbrich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2014
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registryW von Scheidt, C Zugck, M Pauschinger, et al.
Pageof 4